RemeGen Co., Ltd. (HKG:9995)
Hong Kong · Delayed Price · Currency is HKD 85.00
-2.35 (-2.69%)
Oct 30, 2025, 1:44 PM HKT
RemeGen Market Cap
RemeGen has a market cap or net worth of 52.82 billion as of October 29, 2025. Its market cap has increased by 197.32% in one year.
Market Cap
52.82B
Enterprise Value
54.34B
Revenue
2.27B
Ranking
n/a
PE Ratio
n/a
Stock Price
85.00
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 33.39B to 52.82B, an increase of 58.19%. That is a compound annual growth rate of 9.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 52.82B | 277.15% |
| Dec 31, 2024 | 14.00B | -55.02% |
| Dec 29, 2023 | 31.13B | -25.43% |
| Dec 30, 2022 | 41.75B | 9.42% |
| Dec 31, 2021 | 38.16B | -18.00% |
| Dec 31, 2020 | 46.53B | 39.37% |
| Nov 9, 2020 | 33.39B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 269.73B |
| Hansoh Pharmaceutical Group Company | 209.22B |
| JD Health International | 201.53B |
| WuXi Biologics | 149.43B |
| Innovent Biologics | 144.96B |
| Sino Biopharmaceutical | 126.75B |
| Akeso | 105.01B |
| Sichuan Kelun-Biotech Biopharmaceutical | 98.36B |